116 related articles for article (PubMed ID: 3323092)
1. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
[TBL] [Abstract][Full Text] [Related]
2. [A2-Norleucine]insulin. An analog with unanticipated biological properties.
Okada Y; Chanley JD; Burke GT; Katsoyannis PG
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085
[TBL] [Abstract][Full Text] [Related]
3. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
[TBL] [Abstract][Full Text] [Related]
4. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857
[TBL] [Abstract][Full Text] [Related]
6. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
7. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
Chu YC; Zong L; Burke GT; Katsoyannis PG
J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6975-9. PubMed ID: 3322395
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of seventeen analogues of human insulin.
Märki F; de Gasparo M; Eisler K; Kamber B; Riniker B; Rittel W; Sieber P
Hoppe Seylers Z Physiol Chem; 1979 Nov; 360(11):1619-32. PubMed ID: 511097
[TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of covalently linked insulin dimers.
Schüttler A; Brandenburg D
Hoppe Seylers Z Physiol Chem; 1982 Mar; 363(3):317-30. PubMed ID: 7042509
[TBL] [Abstract][Full Text] [Related]
12. Insulin analogues with modifications in the beta-turn of the B-chain.
Wang SH; Hu SQ; Burke GT; Katsoyannis PG
J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
[TBL] [Abstract][Full Text] [Related]
15. An examination of the role of insulin dimerisation and negative cooperativity using the biological properties of the despentapeptide and deshexapeptide insulins.
Cockram CS; Jones RH; Sonksen PH; Tatnell MA; Zhu SQ; Dodson G
Diabetologia; 1987 Sep; 30(9):733-8. PubMed ID: 3322916
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N; Burke GT; Katsoyannis PG
J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I.
Joshi S; Burke GT; Katsoyannis PG
Biochemistry; 1985 Jul; 24(15):4208-14. PubMed ID: 3902081
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.
Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y; Inouye K
Biochem J; 1982 Sep; 206(3):597-603. PubMed ID: 6756393
[TBL] [Abstract][Full Text] [Related]
19. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
Burke GT; Schwartz G; Katsoyannis PG
Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
[TBL] [Abstract][Full Text] [Related]
20. [B17-D-leucine]insulin and [B17-norleucine]insulin: synthesis and biological properties.
Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1615-26. PubMed ID: 6363268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
